The human genome is the collection of genes that comprise all humans. This mapping of the human genome, first completed in 2003, established the baseline. By comparing this baseline with the genes in cancer cells, researchers can isolate the differences and develop targeted drug therapies.
She went on to talk about some of the challenges unique to pediatric cancer research, including obtaining FDA approval, clinical trials often exclude pediatric patients, the rarity of certain pediatric cancers. More importantly, while long-term survival has improved, adult survivors of pediatric cancer remain at risk for a shortened life span, including a secondary cancer diagnosis. IGM studies are committed to changing this reality.
She concluded her presentation by talking about what's next. This research holds promise for improving health outcomes in other areas, including behavioral health, epilepsy, immune response, and infectious diseases.
If you were unable to join the club meeting presentation, this is one you won't want to miss! Click here to view the presentation on our YouTube Channel.